SADC Pharmaceutical Industry

 

Regular Price: USD 6,950

Special Price USD 4,865

30% OFF

* Required Fields

Regular Price: USD 6,950

Special Price USD 4,865

PAY BY INVOICE

Be the first to review this product

This study covers the pharmaceutical industry in key SADC countries, including Malawi, Mauritius and Zambia. The research service provides detailed metrics on the pharmaceutical industries, encompassing the OTC and prescription markets, as well as the branded and generic markets. The research examines drivers and restraints for growth, distribution, and geographical trends. Following from these, market growth are forecasted. In addition, an in-depth analysis of the competitive situation including vendors’ competitive rankings is provided. The base year is 2009 with forecasts running through 2016. The market is further divided into four subsegments including oncology, anti-diabetic drugs, anti-infective drugs and cardiovascular drugs.

Table of Contents

SADC Pharmaceutical Industry, Executive SummarySummary of Key FindingsSummarySADC Pharmaceutical Industry, IntroductionIntroduction to the Objectives Scope and MethodologyAim and ObjectivesResearch ScopeResearch DefinitionsResearch MethodologySADC Pharmaceutical Industry, SADC Pharmaceutical IndustryAn Overview of the SADC Pharmaceutical IndustryIntroductionMarket DynamicsSegmental Revenue ForecastsRevenue Forecasts by Therapeutic SegmentSWOT AnalysisSADC Pharmaceutical Industry, Mauritian Pharmaceutical IndustryAn Overview of the Mauritian Pharmaceutical IndustryCountry OverviewMauritian Healthcare Industry OverviewIntroduction to the Pharmaceutical IndustryMarket Engineering Measurements Pharmaceutical Industry Revenue ForecastsRevenue Growth of Key Segments Therapeutic Segments Revenue Forecasts Competitive StructureLocal ManufacturingCompetitor AnalysisConclusionSADC Pharmaceutical Industry, Malawian Pharmaceutical IndustryAn Overview of the Malawian Pharmaceutical IndustryCountry OverviewMalawian Healthcare Industry OverviewIntroduction to the Pharmaceutical IndustryMarket Engineering MeasurementsPharmaceutical Industry Revenue ForecastsRevenue Growth of Key SegmentsTherapeutic Segments Revenue Forecasts Competitive Structure Competitor AnalysisConclusionSADC Pharmaceutical Industry, Zambian Pharmaceutical IndustryAn Overview of the Zambian Pharmaceutical IndustryCountry OverviewZambian Healthcare Industry OverviewIntroduction to the Pharmaceutical IndustryMarket Engineering Measurements Pharmaceutical Industry Revenue ForecastsRevenue Growth of Key Segments Therapeutic Segments Revenue Forecasts Competitive StructureLocal ManufacturingCompetitor AnalysisConclusionSADC Pharmaceutical Industry, ConclusionKey ConclusionsThe Conclusion




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.